Skip to main content
. 2019 Aug 19;9(6):1145–1162. doi: 10.1016/j.apsb.2019.08.003

Figure 2.

Figure 2

(A) The nanoparticle-based combination therapy. (B) Plasma drug concentrations after i.v. injection of the VYXEOS® liposomes and the free combo drugs in mice (Adapted from Ref. 39 with permission. Copyright © 2016, Elsevier and Ref. 40 with permission. Copyright © 2019, American Association for Cancer).